Europe Continuous Glucose Monitoring (CGM) Devices Market Size, Share and Growth, Analysis and Forecast – 2023
- OI-39 |
- Published date: Nov, 2018 |
- Diabetes Care Devices |
- Pages
Key Trends and Analysis of the Europe Continuous Glucose Monitoring (CGM) Devices Market:
- The Europe continuous glucose monitoring (CGM) devices market is expected to exhibit a CAGR of xx% during the forecast period (2019 – 2023), attributed to the integration of CGM data with insulin pump systems is now allowing some early forays into the automation of basal insulin infusion rates to reduce the risk of hypoglycemia.
- Market growth has been observed due to the edge on, by continuous glucose monitoring devices over traditional glucose monitoring devices with ease real-time glucose measurements, paving way to reduced chronic type II diabetes complications such as averting episodes of hypoglycemia causing reduced overall diabetes care costs and also improving quality of life for the patients
- Key market players operating in the Europe Continuous Glucose Monitoring (CGM) devices market includes xxx, xxx, xxx, etc…
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
Key Trends and Analysis of the Europe Continuous Glucose Monitoring (CGM) Devices Market:
- The Europe continuous glucose monitoring (CGM) devices market is expected to exhibit a CAGR of xx% during the forecast period (2019 – 2023), attributed to the integration of CGM data with insulin pump systems is now allowing some early forays into the automation of basal insulin infusion rates to reduce the risk of hypoglycemia.
- Market growth has been observed due to the edge on, by continuous glucose monitoring devices over traditional glucose monitoring devices with ease real-time glucose measurements, paving way to reduced chronic type II diabetes complications such as averting episodes of hypoglycemia causing reduced overall diabetes care costs and also improving quality of life for the patients
- Key market players operating in the Europe Continuous Glucose Monitoring (CGM) devices market includes xxx, xxx, xxx, etc…
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
